Sponsored Article Image

A message from Curtiss-Wright

High-Temperature neutron flux detectors for Generation IV reactors and SMRs

Learn More

Research & Applications

Astatine-211 targets blood-borne cancers in Seattle clinical trials

September 13, 2022, 9:30AMNuclear News
A clinical dose of At-211 is prepared at the University of Washington for use in a Fred Hutchison Cancer Center clinical trial. (Photo: UW/Don Hamlin)

Scientists in the Departments of Radiation Oncology and Medicine at the University of Washington (UW) and Fred Hutchinson Cancer Center (Fred Hutch) are directly targeting cancerous cells traveling through patients’ bloodstreams with diseases such as leukemia and lymphoma using an intravenous injection of the radioactive isotope astatine-211 (At-211). The work, its challenges, and its promise were described in a recent news release from the National Isotope Development Center (NIDC), which is managed by the Department of Energy’s Isotope Program.

To continue reading, log in or create a free account!

Related Articles

DOE releases 2025 NEUP and NSUF funding

March 6, 2026, 1:06PMNuclear News

On March 3, the Department of Energy announced the release of $52.8 million in funds through the Nuclear Energy University Program (NEUP) and the Nuclear Science User Facilities (NSUF)...

Washington legislators look to nuclear

February 26, 2026, 7:19AMNuclear News

It has been an unusually busy week in the world of West Coast nuclear legislative momentum. In California, a bill is aiming to effectively repeal the state’s nuclear moratorium, while in...

Hanford exhaust stack demolished

February 24, 2026, 1:12PMNuclear News

The Department of Energy’s Office of Environmental Management recently announced that, with the help of contractor Central Plateau Cleanup Company, it has completed the safe demolition of...

Ward250 reactor rides cargo to Utah

February 18, 2026, 9:42AMNuclear News

A public-private partnership between the Departments of Defense and Energy and Valar Atomics marked a milestone over the weekend when Valar’s Ward250 microreactor was transported (without...